Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia

NCT03885011 is registered in ClinicalTrials.gov with Orasis Pharmaceuticals Ltd. as lead sponsor.

NCT NCT03885011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03885011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia
Lead sponsor
Orasis Pharmaceuticals Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 26, 2019
Completion date
July 26, 2019
Enrollment
166 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia